Delayed Umbilical Cord Clamping Versus Cord Milking in Preterm Neonate

February 20, 2013 updated by: Medstar Health Research Institute

Delayed Umbilical Cord Clamping Versus Cord Milking in Preterm Neonate - a Randomized, Controlled Trial

This study is being done to evaluate if delaying cord clamping or milking the umbilical cord of the preterm infant has health benefits for the baby. Timing of clamping of the cord varies among doctors, but there is information that shows that delaying clamping of the umbilical cord in premature infants may reduce the rate of the baby needing a blood transfusion, decrease the risk of infection and bleeding in the head.

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Singleton or multiples pregnancies in patients admitted for medically indicated delivery or in advanced spontaneous preterm labor with imminent delivery at 24 0/7 - 28 6/7 weeks gestation
  • Women ages 18 and older

Exclusion Criteria:

  • Planned vaginal breech delivery
  • Major fetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery)
  • Fetal death in utero
  • Red cell isoimmunization
  • Patients who are incapable of informed consent (unconscious, severely ill, mentally handicapped), or are unwilling to undergo randomization
  • Placenta previa or other known abnormal placentation (e.g. placenta accreta)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Delayed cord clamping
Delayed cord clamping for 30 seconds
Delay cord clamping for 30 seconds after birth
Experimental: Milking of the cord
Milking of the cord 4 times in 10 seconds
Milking of the cord 4 times in 10 seconds
No Intervention: Immediate cord clamping
Immediate cord clamping after delivery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse Neonatal Event
Time Frame: up to 24 weeks after birth
composite of bronchopulmonary dysplasia (BPD), necrotising eneterocolitis (NEC), grade 3 or 4 intraventricular hemorrhage (IVH) or periventricular leukomalacia (PVL), or death prior to discharge home
up to 24 weeks after birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severe intraventricular hemorrhage (grade 3 or 4)
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Phototherapy
Time Frame: up to 24 weeks after birth
Requirement and length of phototherapy
up to 24 weeks after birth
Ionotropic support
Time Frame: up to 24 weeks after birth
Requirement and length of ionotropic support
up to 24 weeks after birth
Necrotizing enterocolitis
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Number of blood transfusions while in the neonatal intensive care unit
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Ventilator time
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Apgar score <7 at 5 minutes
Time Frame: at 5 minutes after birth
at 5 minutes after birth
Umbilical cord pH < 7.0
Time Frame: up to 30 minutes after birth
up to 30 minutes after birth
Polycythemia
Time Frame: up to 24 hours of life
up to 24 hours of life
Neonatal death
Time Frame: up to 24 weeks of life
up to 24 weeks of life
Use of uterotonic agents
Time Frame: up to 1 hour after birth
up to 1 hour after birth
Maternal estimated blood loss
Time Frame: up to 1 hour after delivery
Estimated blood loss at delivery
up to 1 hour after delivery
Any grade intraventricular hemorrhage
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Periventricular leukomalacia
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Bronchopulmonary dysplasia
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Peak transcutaneous and/or serum bilirubin concentrations
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Neonatal intesive care unit (NICU) length of stay
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Sepsis
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Respiratory distress syndrome
Time Frame: up to 24 weeks after birth
up to 24 weeks after birth
Blood pressure on admission to neonatal intensive care unit
Time Frame: at 30 minutes after birth
at 30 minutes after birth
Hematocrit on admission to neonatal intensive care unit
Time Frame: up to 4 hours after birth
up to 4 hours after birth
Length of 3rd stage of labor
Time Frame: up to 1 hour after birth
Time period between delivery of the baby and delivery of the placenta
up to 1 hour after birth
Maternal blood transfusion
Time Frame: up to 5 days after delivery
up to 5 days after delivery
Manual removal of placenta
Time Frame: up to 1 hour after birth
up to 1 hour after birth
Operating time for cesarean delivery
Time Frame: up to 3 hours after birth
up to 3 hours after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rita W Driggers, MD, Washington Hospital Center, Georgetown University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

June 1, 2011

First Submitted That Met QC Criteria

July 12, 2011

First Posted (Estimate)

July 13, 2011

Study Record Updates

Last Update Posted (Estimate)

February 22, 2013

Last Update Submitted That Met QC Criteria

February 20, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on Delayed cord clamping

3
Subscribe